Medical Health & Life Science Research News

Immunohistochemistry (IHC) market forecast to 2022 illuminated by new report

The global immunohistochemistry (IHC) market is witnessing considerable growth due to increasing geriatric population, increasing healthcare expenditure and growing awareness about histopathology.

Moreover, growing prevalence of chronic diseases including cancer, cardiovascular disease, infectious diseases, autoimmune diseases, diabetes mellitus, and nephrological diseases is supporting the growth of the market. Based on product type, the kit segment is expected to grow at faster rate during the forecast period.

The increasing adoption of IHC kit across the globe, owing to its ease of use, availability of ready to use reagents and antibodies, and optimized sensitivity of the antibody to the antigen, is driving the growth of this segment.

Explore Report at:www.psmarketresearch.com/market-an…ochemistry-market

The rapid growth in emerging economies and technological development in the in vitro diagnostics industry is expected to create opportunities for the manufacturers of IHC kit, equipment and reagent. However, high cost of IHC equipment is the key factor hampering the growth of the global market.

Request to Sample: www.psmarketresearch.com/market-an…ket/report-sample

IHC is used by public or private organizations to check localization and distribution of specific cellular components within the cells. It is a technique which combines immunological, anatomical, and biochemical processes to identify tissue components by the interaction of target antigens with specific antibodies that are tagged by a label.

Report Enquiry at:  www.psmarketresearch.com/send-enqu…ochemistry-market

Geographically, North America has been the largest market for IHC, owing to increased awareness, established healthcare industry, and easy accessibility to advanced technologies. The U.S. contributed largest revenue to the North American as well as global IHC market.

The advanced cancer diagnostic testing and cancer screening is the key growth driving factor for the U.S. IHC market.

 Get More Information Visit:  P&S Market Research

The key players operating in the global IHC market are F. Hoffmann-LA Roche AG, Danaher Corporation, Agilent Technologies, Inc., Thermo Fisher Scientific Inc., Merck Millipore, Bio-Rad Laboratories, Inc., Perkinelmer, Inc., Cell Signaling Technology, Inc., Bio SB and Abcam PLC.

News From

P&S Market ResearchP&S Market Research
Category: Market Research Publishers and RetailersCompany profile: PS Market Research is a global market research and consulting company. We provide market research reports, industry reports, business intelligence and research based consulting services across a range of industries. With the help of our professional corporate relations with various companies, our market research offers the most accurate market forecasting. Our analysts and consultants interact with leading companies of the concerned domain to substantiate every single data presented in our pub ...

For more information:

Make an Inquiry about this report HERE!
  • www.psmarketresearch.com/market-an…ochemistry-market
  • www.psmarketresearch.com/market-an…ket/report-sample
  • www.psmarketresearch.com/send-enqu…ochemistry-market
  • www.facebook.com/pages/PS-Market-R…h/743236225753851
  • twitter.com/psresearchmarke
  • www.linkedin.com/company/p&s-market-research